Pharvaris NV
Pharvaris NV (PHVS) Wheel Strategy
PHVS wheel strategy scan found 10 cash-secured put setups on the previous trading day. Probability of expiring worthless is above 50%. Annualized returns reach up to 156.4%.
Read more
Running a PHVS wheel strategy lets you generate consistent premium income on Pharvaris NV while setting your own entry and exit prices on the underlying. Pharvaris NV's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own PHVS, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best PHVS wheel strategy setups in real time.
The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on PHVS, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable PHVS wheel from a losing one.
Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, rapid exposure soft capsule for patients suffering from acute HAE attacks and is under Phase 2 clinical trial; and PHVS719, a prophylactic extended-release tablet for HAE patients and is under Phase 1 clinical trial. It operates in the Netherlands, Switzerland, and the United States.
The company was incorporated in 2015 and is based in Leiden, the Netherlands.
The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the PHVS wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your PHVS wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.
| Sep 18, 2026 | 35.00 | $0.15 | $0.30 | -0.18 | 2 | — | 96.4% | 156.4% | 158 |
| Oct 16, 2026 | 35.00 | $0.75 | $1.18 | -0.29 | 30 | — | 64.6% | 40.8% | 269 |
| Jan 15, 2027 | 35.00 | $2.75 | $4.38 | -0.34 | 121 | — | 53.7% | 37.7% | 50 |
| Dec 18, 2026 | 35.00 | $1.05 | $3.28 | -0.34 | 93 | — | 55.5% | 36.7% | 32 |
| Mar 19, 2027 | 35.00 | $2.55 | $4.98 | -0.34 | 184 | — | 50.9% | 28.2% | 0 |
| Jan 15, 2027 | 30.00 | $0.05 | $2.48 | -0.22 | 121 | — | 71.4% | 24.9% | 192 |
| Mar 19, 2027 | 25.00 | $0.05 | $2.48 | -0.16 | 184 | — | 80.5% | 19.6% | 5 |
| Mar 19, 2027 | 30.00 | $0.50 | $2.70 | -0.22 | 184 | — | 65.8% | 17.9% | 2 |
| Dec 18, 2026 | 30.00 | $0.20 | $1.25 | -0.18 | 93 | — | 75.1% | 16.4% | 61 |
| Oct 16, 2026 | 30.00 | $0.20 | $0.30 | -0.09 | 30 | — | 90.8% | 12.2% | 6,039 |
As of September 17, 2026
Run the Wheel on PHVS With Confidence
Find the best PHVS wheel strategy setups across strikes and expirations, plan ahead with at-strike values, and keep your covered calls and puts on track.
Start your 14-day free trial→